Global Live Cell Imaging Markets Research Report 2021-2027: Focus on Fluorescence Resonance Energy Transfer & High Content Screening
November 03, 2021 10:58 ET
|
Research and Markets
Dublin, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Market based on Product, Application, Technology - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's...
Worldwide Preclinical CRO Industry to 2028 - Featuring Wuxi App, Medpace and ICON Among Others
October 12, 2021 07:43 ET
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use...
Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
October 04, 2021 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
NIH/NINDS Awards AnaBios With $1.7M Grant to Develop Novel Analgesic for Mixed Inflammatory, Neuropathic Pain States
September 30, 2021 11:00 ET
|
AnaBios
SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded AnaBios a $1,734,409...
Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories
August 02, 2021 12:15 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity
May 27, 2021 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Kenneth Swart, Ph.D., Joins Inotiv as Vice President, Bioanalytical Sciences to Drive Growth of Expanding Laboratory Solutions Offerings
May 11, 2021 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 11, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.
April 30, 2021 15:40 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 30, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Plan to Expand the Company’s Internal Operations
April 19, 2021 07:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 19, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
April 16, 2021 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research...